For citations:
Wirth A. Reduction of body weight and comorbidities by xenical (orlistat): The XXL- primary health care trial. Problems of Endocrinology. 2006;52(3):21-25. (In Russ.) https://doi.org/10.14341/probl200652321-25
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
